College of
Business
Administration
College of
Business
Administration
1) What is corporate social performance, and how does it differ from corporate social responsibility?
2) Is a company's social performance a matter of 'results' or 'intentions'?
3) Why do corporations publicize their acts of philanthropy?
4) Does a commitment to socially responsible behavior improve an organization? In what specific ways?
5) If a corporate program leads to a desirable social end but prompts a price increase, is the company behaving in a socially responsible manner? What reasoining can be used to support your conclusion?
6) For companies without a history of positive social performance, how can such a program be initiated?
7) Should a company's product/output be considered when assessing the company's corporate social performance, or does CSP exist independently?
The following questions relate to the Merck case...
8) Did Merck have an ethical obligation to develop Mectizan?
9) What were the motives for developing and distributing Mectizan? How do you know?
10) How does Merck justify the cost of development and distribution of Mectizan to shareholders? Is it important that they do so?
11) If Merck knew they would not receive any support from the government or other world agencies, do you think they would have started the development?
12) Once Merck started the development and received public recognition does the firm have the option of curtailing it, given the distributional difficulties encountered? What might be the effects, both internally and externally, of doing so?
13) If you were the senior executive, what would you have done in this case?
Return to Professor Dunn's home page.